| Heart Failure (HF) |
1 |
1 |
| Thromboembolism |
0 |
0.89 |
| Atrial Fibrillation |
0 |
0.87 |
| Cardiovascular Imaging |
0 |
0.78 |
| Cardiac Surgery |
0 |
0.77 |
| Hypertension |
0 |
0.7 |
| Cerebrovascular Accident |
0 |
0.64 |
| Heart |
0 |
0.57 |
| Coronary Artery Disease (CAD) |
0 |
0.53 |
| Arrhythmia |
0 |
0.52 |
| Valvular Heart Disease |
0 |
0.42 |
| Clinical Guidelines |
0 |
0.39 |
| SGLT2 Inhibitor |
0 |
0.34 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.32 |
| Ejection Fraction |
0 |
0.31 |
| HIV Infection |
0 |
0.31 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.29 |
| COVID-19 |
0 |
0.28 |
| Lipids Management |
0 |
0.27 |
| Cholesteryl Ester Transfer Protein (CETP) Inhibitor |
0 |
0.25 |
| Type 2 Diabetes Mellitus |
0 |
0.23 |
| Ablation |
0 |
0.21 |
| Anticoagulation Therapy |
0 |
0.21 |
| Europe |
0 |
0.21 |
| Transcatheter Aortic Valve Replacement |
0 |
0.21 |
| Stent |
0 |
0.18 |
| Catheter Ablation |
0 |
0.17 |
| Chronic Kidney Disease |
0 |
0.17 |
| Renal Failure |
0 |
0.17 |
| Coronary Stent |
0 |
0.15 |
| Angiography |
0 |
0.14 |
| Artery |
0 |
0.14 |
| Cardiac Resynchronization Therapy |
0 |
0.14 |
| Endarterectomy |
0 |
0.14 |
| Kansas |
0 |
0.14 |
| Influenza Vaccine |
0 |
0.13 |
| Myocardial Infarction (MI) |
0 |
0.13 |
| Closure Device |
0 |
0.11 |
| Immunization |
0 |
0.11 |
| Pandemic |
0 |
0.11 |
| Sodium Restriction |
0 |
0.11 |
| Thrombosis |
0 |
0.11 |
| Acute Coronary Syndrome |
0 |
0.1 |
| Cardiothoracic Surgery |
0 |
0.09 |
| Acute Respiratory Distress Syndrome |
0 |
0.07 |
| Aspirin |
0 |
0.07 |
| Embolism |
0 |
0.07 |
| Hemorrhage |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Infarction |
0 |
0.07 |
| Influenza |
0 |
0.07 |
| Prophylaxis |
0 |
0.07 |
| Quality of Life |
0 |
0.07 |
| Receptors |
0 |
0.07 |
| Renal Disease |
0 |
0.07 |
| Severe Acute Respiratory Syndrome |
0 |
0.07 |
| Surgery |
0 |
0.07 |
| Thoracic Surgery |
0 |
0.07 |
| Electrophysiology |
0 |
0.06 |
| Implantable Cardioverter-Defibrillator |
0 |
0.05 |
| Anti-inflammatory Agents |
0 |
0.04 |
| Antiviral Agents |
0 |
0.04 |
| Aortic Valve |
0 |
0.04 |
| Attending Physician |
0 |
0.04 |
| Beta Blockers |
0 |
0.04 |
| Blood |
0 |
0.04 |
| Calcaneal |
0 |
0.04 |
| Cardiac Arrest |
0 |
0.04 |
| Cerebrovascular Accident History |
0 |
0.04 |
| Clinical Research |
0 |
0.04 |
| Defibrillator |
0 |
0.04 |
| Diet |
0 |
0.04 |
| Factor X |
0 |
0.04 |
| Health Care Cost |
0 |
0.04 |
| Health Care Economics |
0 |
0.04 |
| Intensive Care Unit |
0 |
0.04 |
| Isolation |
0 |
0.04 |
| Jobs |
0 |
0.04 |
| New York |
0 |
0.04 |
| Orbit |
0 |
0.04 |
| Renin-Angiotensin System |
0 |
0.04 |
| Scar |
0 |
0.04 |
| Stroke Risk |
0 |
0.04 |
| Tissue |
0 |
0.04 |
| Uncontrolled Hypertension |
0 |
0.04 |
| Valve Replacement |
0 |
0.04 |
| Vein |
0 |
0.04 |
| Venous Thromboembolism (VTE) |
0 |
0.04 |
| Vitamin |
0 |
0.04 |
| Mechanical Ventilation |
0 |
0.03 |
| Social Determinants of Health |
0 |
0.03 |
| Vaccines |
0 |
0.03 |